HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Wei Selected Research

Phenobarbital (Luminal)

1/2021Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.
7/2017Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
1/2011Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis.
7/2009Cytokeratin 8/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Wei Research Topics

Disease

164Neoplasms (Cancer)
05/2024 - 08/2002
36Carcinogenesis
05/2024 - 08/2002
20Breast Neoplasms (Breast Cancer)
01/2023 - 08/2011
17Infections
01/2023 - 09/2007
14Pain (Aches)
03/2024 - 08/2007
13Melanoma (Melanoma, Malignant)
10/2023 - 11/2005
13Body Weight (Weight, Body)
04/2020 - 09/2002
12Wounds and Injuries (Trauma)
03/2024 - 02/2002
12Inflammation (Inflammations)
12/2023 - 12/2005
12Neoplasm Metastasis (Metastasis)
02/2023 - 07/2004
10Glioma (Gliomas)
04/2024 - 06/2008
10Alzheimer Disease (Alzheimer's Disease)
01/2024 - 05/2002
9Prostatic Neoplasms (Prostate Cancer)
01/2020 - 05/2012
9Carcinoma (Carcinomatosis)
10/2014 - 01/2003
8Hemorrhage
11/2023 - 08/2007
8Starvation
10/2016 - 06/2008
7Cognitive Dysfunction
01/2024 - 01/2009
7Stomach Neoplasms (Stomach Cancer)
02/2023 - 06/2010
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 11/2004
7Adenocarcinoma
01/2023 - 01/2005
7COVID-19
01/2022 - 07/2020
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2017 - 01/2003
6Stroke (Strokes)
11/2023 - 02/2011
6Hypoxia (Hypoxemia)
01/2023 - 03/2014
6Congenital Abnormalities (Deformity)
02/2022 - 09/2003
6Hyperplasia
09/2013 - 08/2002
5Insulin Resistance
02/2024 - 02/2011
5Lung Neoplasms (Lung Cancer)
01/2024 - 08/2004
5Parkinson Disease (Parkinson's Disease)
12/2023 - 01/2019
5Hyperlipidemias (Hyperlipidemia)
03/2022 - 10/2004
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 08/2007
5Adenocarcinoma of Lung
07/2020 - 01/2012
5Hypertelorism
03/2020 - 09/2003
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 04/2006
5Leukemia
01/2019 - 03/2003
4Type 2 Diabetes Mellitus (MODY)
01/2024 - 03/2011
4Multiple Myeloma
12/2023 - 01/2019
4Ischemic Stroke
11/2023 - 01/2021
4Fibrosis (Cirrhosis)
11/2023 - 01/2011
4Glioblastoma (Glioblastoma Multiforme)
01/2023 - 04/2012
4Heart Failure
09/2022 - 04/2009
4Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 01/2016
4Stress Fractures (Stress Fracture)
02/2022 - 05/2011
4Acquired Immunodeficiency Syndrome (AIDS)
07/2021 - 06/2003
4Hepatocellular Carcinoma (Hepatoma)
03/2021 - 07/2009
4Colonic Neoplasms (Colon Cancer)
01/2021 - 12/2003
4Proteinuria
06/2019 - 12/2015
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 01/2013

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
03/2024 - 02/2002
26Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2009
14EnzymesIBA
05/2024 - 01/2005
13Long Noncoding RNAIBA
01/2023 - 05/2012
13Messenger RNA (mRNA)IBA
01/2022 - 08/2003
12Glucose (Dextrose)FDA LinkGeneric
01/2021 - 06/2008
12CarcinogensIBA
03/2011 - 10/2002
11MicroRNAs (MicroRNA)IBA
01/2023 - 07/2012
10DNA (Deoxyribonucleic Acid)IBA
01/2023 - 08/2004
8Therapeutic UsesIBA
01/2024 - 08/2007
8RNA (Ribonucleic Acid)IBA
01/2024 - 06/2010
7AntigensIBA
09/2023 - 03/2011
7Reactive Oxygen Species (Oxygen Radicals)IBA
09/2023 - 08/2002
7Insulin (Novolin)FDA Link
01/2020 - 02/2011
7Glutathione Transferase (Glutathione S-Transferase)IBA
01/2011 - 08/2003
6Indicators and Reagents (Reagents)IBA
02/2024 - 07/2009
6AntibodiesIBA
01/2024 - 09/2009
6LipidsIBA
10/2023 - 09/2002
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 09/2002
6AcidsIBA
01/2023 - 10/2007
6SolutionsIBA
04/2017 - 01/2002
6Diethylnitrosamine (N-Nitrosodiethylamine)IBA
11/2013 - 01/2006
5Small Interfering RNA (siRNA)IBA
01/2024 - 03/2011
5Transcription Factors (Transcription Factor)IBA
12/2023 - 10/2016
5AnticoagulantsIBA
11/2023 - 07/2004
5Interleukin-6 (Interleukin 6)IBA
10/2023 - 08/2014
5Immunoglobulin G (IgG)IBA
06/2023 - 01/2018
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 01/2007
5Tumor Biomarkers (Tumor Markers)IBA
03/2020 - 12/2009
5Insulin-Like Growth Factor I (IGF-1)IBA
03/2014 - 09/2002
5Heparin (Liquaemin)FDA LinkGeneric
02/2012 - 07/2004
5ArsenicIBA
06/2006 - 08/2002
4Peptides (Polypeptides)IBA
05/2024 - 03/2012
4LigandsIBA
01/2024 - 12/2012
4CytokinesIBA
10/2023 - 07/2011
4Immune Checkpoint InhibitorsIBA
01/2023 - 10/2020
4VaccinesIBA
11/2021 - 06/2003
4GlycogenIBA
09/2021 - 02/2005
4Phenobarbital (Luminal)FDA Link
01/2021 - 07/2009
4Hormones (Hormone)IBA
12/2020 - 01/2009
4Telomerase (Telomerase Reverse Transcriptase)IBA
11/2017 - 01/2016

Therapy/Procedure

67Therapeutics
04/2024 - 03/2004
18Drug Therapy (Chemotherapy)
01/2023 - 06/2008
14Debridement
03/2024 - 04/2010
10Immunotherapy
04/2024 - 01/2020
8Osteotomy
03/2020 - 09/2003
7Radiotherapy
01/2023 - 01/2012
6Lasers (Laser)
01/2023 - 07/2009
5Sutures (Suture)
01/2024 - 08/2011
5Precision Medicine
12/2020 - 04/2018
5Synovectomy
03/2017 - 08/2007
4Chemoradiotherapy
12/2022 - 05/2018